These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2668 related articles for article (PubMed ID: 33688063)

  • 1. SARS-CoV-2 within-host diversity and transmission.
    Lythgoe KA; Hall M; Ferretti L; de Cesare M; MacIntyre-Cockett G; Trebes A; Andersson M; Otecko N; Wise EL; Moore N; Lynch J; Kidd S; Cortes N; Mori M; Williams R; Vernet G; Justice A; Green A; Nicholls SM; Ansari MA; Abeler-Dörner L; Moore CE; Peto TEA; Eyre DW; Shaw R; Simmonds P; Buck D; Todd JA; ; Connor TR; Ashraf S; da Silva Filipe A; Shepherd J; Thomson EC; ; Bonsall D; Fraser C; Golubchik T
    Science; 2021 Apr; 372(6539):. PubMed ID: 33688063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity.
    Huang SW; Wang SF
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.
    Armero A; Berthet N; Avarre JC
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins.
    Sahin E; Bozdayi G; Yigit S; Muftah H; Dizbay M; Tunccan OG; Fidan I; Caglar K
    J Med Virol; 2021 Oct; 93(10):6016-6026. PubMed ID: 34241906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of within-host genetic diversity in SARS-CoV-2.
    Tonkin-Hill G; Martincorena I; Amato R; Lawson ARJ; Gerstung M; Johnston I; Jackson DK; Park N; Lensing SV; Quail MA; Gonçalves S; Ariani C; Spencer Chapman M; Hamilton WL; Meredith LW; Hall G; Jahun AS; Chaudhry Y; Hosmillo M; Pinckert ML; Georgana I; Yakovleva A; Caller LG; Caddy SL; Feltwell T; Khokhar FA; Houldcroft CJ; Curran MD; Parmar S; ; Alderton A; Nelson R; Harrison EM; Sillitoe J; Bentley SD; Barrett JC; Torok ME; Goodfellow IG; Langford C; Kwiatkowski D;
    Elife; 2021 Aug; 10():. PubMed ID: 34387545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.
    Leung K; Shum MH; Leung GM; Lam TT; Wu JT
    Euro Surveill; 2021 Jan; 26(1):. PubMed ID: 33413740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks.
    Braun KM; Moreno GK; Wagner C; Accola MA; Rehrauer WM; Baker DA; Koelle K; O'Connor DH; Bedford T; Friedrich TC; Moncla LH
    PLoS Pathog; 2021 Aug; 17(8):e1009849. PubMed ID: 34424945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants.
    Rotondo JC; Martini F; Maritati M; Mazziotta C; Di Mauro G; Lanzillotti C; Barp N; Gallerani A; Tognon M; Contini C
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
    J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2.
    Ringlander J; Fingal J; Kann H; Prakash K; Rydell G; Andersson M; Martner A; Lindh M; Horal P; Hellstrand K; Kann M
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35064076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
    Peacock TP; Penrice-Randal R; Hiscox JA; Barclay WS
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33855951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 evolution during treatment of chronic infection.
    Kemp SA; Collier DA; Datir RP; Ferreira IATM; Gayed S; Jahun A; Hosmillo M; Rees-Spear C; Mlcochova P; Lumb IU; Roberts DJ; Chandra A; Temperton N; ; ; Sharrocks K; Blane E; Modis Y; Leigh KE; Briggs JAG; van Gils MJ; Smith KGC; Bradley JR; Smith C; Doffinger R; Ceron-Gutierrez L; Barcenas-Morales G; Pollock DD; Goldstein RA; Smielewska A; Skittrall JP; Gouliouris T; Goodfellow IG; Gkrania-Klotsas E; Illingworth CJR; McCoy LE; Gupta RK
    Nature; 2021 Apr; 592(7853):277-282. PubMed ID: 33545711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
    Jung C; Kmiec D; Koepke L; Zech F; Jacob T; Sparrer KMJ; Kirchhoff F
    J Virol; 2022 Mar; 96(6):e0207721. PubMed ID: 35225672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
    Gupta AM; Chakrabarti J; Mandal S
    Microbes Infect; 2020; 22(10):598-607. PubMed ID: 33049387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulation and Evolution of SARS-CoV-2 in India: Let the Data Speak.
    Limaye S; Kasibhatla SM; Ramtirthkar M; Kinikar M; Kale MM; Kulkarni-Kale U
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 134.